Monkeypox test marketer Virax rallies 120% after NYC declares public health emergency [Seeking Alpha]
Virax Biolabs Group Limited (VRAX)
Company Research
Source: Seeking Alpha
Monkeypox test marketer Virax rallies 120% after NYC declares public health emergencyAug. 01, 2022 1:37 PM ETVirax Biolabs Group Limited (VRAX)By:Val KennedySA News Editor1 CommentMikko Lemola/iStock via Getty ImagesAfter plunging 74% Friday, shares of monkeypox test marketer Virax Biolabs (NASDAQ:stock opened at $7.48, sliding to a low of $6.98 in early trading before climbing to a high of $13.75 in late morning. The stock recently changed hands at $11.86, up 120% from Fridayâ??s close, at approximately 1:30 p.m. ET.Based in London, Virax sells diagnostic test kits for illnesses such as monkeypox and COVID-19, along with personal protection equipment. The companyannounced last weekVirax shares have been highly volatile since the companywent public through a $7M initial public offeringTrading for the stock was particularly wild on Friday, when shares hit an all-time high of $29 and then tumbled to close at an all-time low of $5.40.Several other makers of diagnostic tests also rallied
Show less
Read more
Impact Snapshot
Event Time:
VRAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRAX alerts
High impacting Virax Biolabs Group Limited news events
Weekly update
A roundup of the hottest topics
VRAX
News
- EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes [Yahoo! Finance]Yahoo! Finance
- Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 [Yahoo! Finance]Yahoo! Finance
- Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024PR Newswire
- Virax Biolabs to Participate at ESCMID Global 2024 [Yahoo! Finance]Yahoo! Finance
- Virax Biolabs to Participate at ESCMID Global 2024PR Newswire
VRAX
Sec Filings
- 4/25/24 - Form 6-K
- 4/16/24 - Form 6-K
- 3/15/24 - Form 6-K
- VRAX's page on the SEC website